Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
The clinical course of a patient with polycythemia vera and proteinuria whose biopsy lead to a diagnosis of focal segmental glomerulosclerosis is described.
Diagnosis & Disease Information
Patients With MPNs, Physicians View Treatment Goals Differently
Patients with myeloproliferative neoplasms, such as polycythemia vera and myelofibrosis, and their physicians frequently view the assessment of disease prognosis, disease burden, and treatment goals differently.
Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
Ruxolitinib is an effective long-term treatment option for patients with polycythemia resistant or intolerant to hydroxyurea, according to a study presented at the 2016 European Hematology Association Congress.
- Loading...
Loading...
Next post in Leukemia
Loading... 
Loading...